Search Results - "Glezerman, Ilya G."

Kidney Complications of Immune Checkpoint Inhibitors: A Review by Shingarev, Roman, Glezerman, Ilya G.

“…Immunologic control of malignancy has long been recognized as an important determinant of disease progression. Recent advances in immunology have led to the…”
Get full text

Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study by Cortazar, Frank B, Kibbelaar, Zoe A, Glezerman, Ilya G, Abudayyeh, Ala, Mamlouk, Omar, Motwani, Shveta S, Murakami, Naoka, Herrmann, Sandra M, Manohar, Sandhya, Shirali, Anushree C, Kitchlu, Abhijat, Shirazian, Shayan, Assal, Amer, Vijayan, Anitha, Renaghan, Amanda DeMauro, Ortiz-Melo, David I, Rangarajan, Sunil, Malik, A Bilal, Hogan, Jonathan J, Dinh, Alex R, Shin, Daniel Sanghoon, Marrone, Kristen A, Mithani, Zain, Johnson, Douglas B, Hosseini, Afrooz, Uprety, Deekchha, Sharma, Shreyak, Gupta, Shruti, Reynolds, Kerry L, Sise, Meghan E, Leaf, David E

“…Despite increasing recognition of the importance of immune checkpoint inhibitor-associated AKI, data on this complication of immunotherapy are sparse. We…”
Get full text

Long-Term Renal Outcomes after Cisplatin Treatment by Latcha, Sheron, Jaimes, Edgar A, Patil, Sujata, Glezerman, Ilya G, Mehta, Swati, Flombaum, Carlos D

“…Nephrotoxicity remains the dose-limiting side effect of cisplatin, an effective chemotherapeutic agent with applications across diverse tumor types. This study…”
Get full text

Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance by Rosner, Mitchell H, Edeani, Amaka, Yanagita, Motoko, Glezerman, Ilya G, Leung, Nelson

“…Paraprotein-related kidney disease represents a complex group of diseases caused by an abnormal paraprotein secreted by a clone of B cells. The disease…”
Get full text

Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma by Wanchoo, Rimda, Abudayyeh, Ala, Doshi, Mona, Edeani, Amaka, Glezerman, Ilya G, Monga, Divya, Rosner, Mitchell, Jhaveri, Kenar D

“…Survival for patients with multiple myeloma has significantly improved in the last decade in large part due to the development of proteasome inhibitors and…”
Get full text

Brincidofovir for Polyomavirus-Associated Nephropathy After Allogeneic Hematopoietic Stem Cell Transplantation by Papanicolaou, Genovefa A., MD, Lee, Yeon Joo, MD, Young, James W., MD, Seshan, Surya V., MB BS, Boruchov, Adam M., MD, Chittick, Gregory, BS, Momméja-Marin, Herve, MD, Glezerman, Ilya G., MD

“…Polyomavirus-associated nephropathy (PVAN) is common in patients who have undergone kidney transplantation and has been reported in hematopoietic stem cell…”
Get full text

Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer by Abramson, Matthew, Glezerman, Ilya G, Srinivasan, Maya, Ross, Richard, Flombaum, Carlos, Gutgarts, Victoria

“…Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by factor-induced dysregulation of phosphate and vitamin D metabolism…”
Get more information

Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature by Usui, Joichi, MD, PhD, Glezerman, Ilya G., MD, Salvatore, Steven P., MD, Chandran, Chandra B., MD, Flombaum, Carlos D., MD, Seshan, Surya V., MD

“…Summary Recently, cancer therapies have been supplemented by vascular endothelial growth factor (VEGF) inhibitors as anti-angiogenic agents. However,…”
Get full text

Kidney Tubular Toxicity of Maintenance Pemetrexed Therapy by Glezerman, Ilya G., MD, Pietanza, M. Catherine, MD, Miller, Vincent, MD, Seshan, Surya V., MB,BS

“…Pemetrexed is an antifolate agent approved for the treatment of advanced lung cancer. Major side effects include myelosuppression and neutropenia. Three…”
Get full text

Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide Phosphoribosyltransferase by Zheng, Jian, Glezerman, Ilya G., Sadot, Eran, McNeil, Anjuli, Zarama, Cristina, Gönen, Mithat, Creasy, John, Pak, Linda M., Balachandran, Vinod P., D'Angelica, Michael I., Allen, Peter J., DeMatteo, Ronald P., Kingham, T. Peter, Jarnagin, William R., Jaimes, Edgar A.

“…Postoperative hypophosphatemia is common and is associated with a lower risk of liver failure after hepatectomy, but higher morbidity after pancreatectomy…”
Get full text

Two cases of spontaneous remission of non-parasitic chyluria by Mendu, Damodara Rao, Sternlicht, Hillel, Ramanathan, Lakshmi V., Pessin, Melissa S., Fleisher, Martin, Dalbagni, Guido, Jaimes, Edgar A., Kaltsas, Anna, Glezerman, Ilya G.

“…Chyluria is a medical condition with presence of chyle in urine. The disease is most prevalent in South East Asian countries mostly caused by parasitic…”
Get full text

Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors by Cortazar, Frank B, Marrone, Kristen A, Troxell, Megan L, Ralto, Kenneth M, Hoenig, Melanie P, Brahmer, Julie R, Le, Dung T, Lipson, Evan J, Glezerman, Ilya G, Wolchok, Jedd, Cornell, Lynn D, Feldman, Paul, Stokes, Michael B, Zapata, Sarah A, Hodi, F Stephen, Ott, Patrick A, Yamashita, Michifumi, Leaf, David E

“…Immune checkpoint inhibitors (CPIs), monoclonal antibodies that target inhibitory receptors expressed on T cells, represent an emerging class of immunotherapy…”
Get more information

Hypercalcemia of malignancy and new treatment options by Sternlicht, Hillel, Glezerman, Ilya G

“…Hypercalcemia of malignancy affects up to one in five cancer patients during the course of their disease. It is associated with both liquid malignancies,…”
Get full text

Denosumab for Treatment of Hypercalcemia of Malignancy by Hu, Mimi I, Glezerman, Ilya G, Leboulleux, Sophie, Insogna, Karl, Gucalp, Rasim, Misiorowski, Waldemar, Yu, Bennett, Zorsky, Paul, Tosi, Diego, Bessudo, Alberto, Jaccard, Arnaud, Tonini, Giuseppe, Ying, Wendy, Braun, Ada, Jain, Rajul K

“…Context: Hypercalcemia of malignancy (HCM) in patients with advanced cancer is often caused by excessive osteoclast-mediated bone resorption. Patients may not…”
Get full text

The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients by Castillo, Jorge J, Glezerman, Ilya G, Boklage, Susan H, Chiodo, 3rd, Joseph, Tidwell, Beni A, Lamerato, Lois E, Schulman, Kathy L

“…Hyponatremia is prognostic of higher mortality in some cancers but has not been well studied in others. We used a longitudinal design to determine the…”
Get full text

Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: CON by Gutgarts, Victoria, Glezerman, Ilya G

Get full text

Effect of mannitol on cisplatin-associated acute kidney injury: a target trial emulation by Gupta, Shruti, Glezerman, Ilya G, Hirsch, Jamie S, Wells, Sophia L, Chen, Kevin L, Seitter, Robert H, Monson, Audrey E, Green-Lingren, Olivia, Jhaveri, Kenar D, Page, Valda D, Abramson, Matthew H, Bansal, Anip, Abudayyeh, Ala, Leaf, David E

Get full text

Hypertension and VEGF (Vascular Endothelial Growth Factor) Receptor Tyrosine Kinase Inhibition: Effects on Renal Function by Boursiquot, Brian C, Zabor, Emily C, Glezerman, Ilya G, Jaimes, Edgar A

“…VEGF (vascular endothelial growth factor) receptor tyrosine kinase inhibitors have become first-line therapy for metastatic renal cell carcinoma. Their use…”
Get full text

Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study by Gupta, Shruti, Glezerman, Ilya G, Hirsch, Jamie S, Chen, Kevin L, Devaraj, Nishant, Wells, Sophia L, Seitter, Robert H, Kaunfer, Sarah A, Jose, Arunima M, Rao, Shreya P, Ortega, Jessica L, Green-Lingren, Olivia, Hayden, Robert, Bendapudi, Pavan K, Chute, Donald F, Sise, Meghan E, Jhaveri, Kenar D, Page, Valda D, Abramson, Matthew H, Motwani, Shveta S, Xu, Wenxin, Sehgal, Kartik, Reynolds, Kerry L, Bansal, Anip, Abudayyeh, Ala, Leaf, David E

“…To develop and externally validate a prediction model for severe cisplatin associated acute kidney injury (CP-AKI). Multicenter cohort study. Six…”
Get more information

Management of Patients with Acute Methotrexate Nephrotoxicity with High‐Dose Leucovorin by Flombaum, Carlos D., Liu, Dazhi, Yan, Shirley Qiong, Chan, Amelia, Mathew, Sherry, Meyers, Paul A., Glezerman, Ilya G., Muthukumar, Thangamani

“…Background Acute kidney injury complicating high‐dose methotrexate (HDMTX) therapy increases the risk for severe mucositis, myelosuppression, and death. It is…”
Get full text